ライフサイエンスコーパス: mammary artery

1 P<0.05 for both saphenous veins and internal mammary arteries).

2 pressed in human saphenous vein and internal mammary artery.

3 cardiopulmonary bypass with a left internal mammary artery.

4 ower patency rates compared to left internal mammary artery.

5 d in segments of saphenous vein and internal mammary artery.

6 ial artery behaves similarly to the internal mammary artery.

7 function and O(2)(.-) generation in internal mammary arteries.

8 and reduced O(2)(.-) generation in internal mammary arteries.

9 In rings of intact internal mammary artery, 1 microM of atrial natriuretic peptide (

10 Among the 796 CABG grafts (345 left internal mammary artery, 12 right internal mammary artery/radial,

11 ter (EC(50)=33+/-7 nmol/L) than the internal mammary artery (203+/-32 nmol/L) or saphenous vein (97+/

12 ter in radial artery (39+/-5%) than internal mammary artery (23+/-6%) or saphenous vein (5+/-2%, both

13 pmol/mg protein) compared with the internal mammary artery (3.5+/-1.3 pmol/mg protein) or saphenous

14 10%) was significantly greater than internal mammary artery (56+/-9%) or saphenous vein (11+/-5%, bot

15 l/mg protein) was also greater than internal mammary artery (6.2+/-0.3 pmol/mg protein) or saphenous

16 nificantly lower than that for left internal mammary arteries (90.3%, P<0.0001) or saphenous vein gra

17 ents with human saphenous veins and internal mammary arteries, adiponectin induced Akt-mediated eNOS

18 eriments with human saphenous veins/internal mammary arteries and adipose tissue, we demonstrated tha

19 Segments of saphenous vein and internal mammary artery and confluent smooth muscle cells culture

20 duit selection, including bilateral internal mammary artery and radial artery use; intraoperative gra

21 Segments of internal mammary artery and saphenous vein from patients undergoi

22 have lower patency rates than left internal mammary artery and saphenous vein grafts.

23 Segments of internal mammary artery and saphenous vein were obtained during c

24 al and patient consent, segments of internal mammary artery and saphenous vein were obtained during c

25 n separate experiments, segments of internal mammary artery and saphenous vein were obtained from fiv

26 Segments of internal mammary artery and saphenous vein were obtained from pat

27 f the radial artery to those of the internal mammary artery and saphenous vein.

28 nary artery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were recruite

29 we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, r

30 h vessel bed, correlates with contraction in mammary artery, and is modulated by aging.

31 Matched segments of radial artery, internal mammary artery, and saphenous vein (n=24 patients) were

32 hemically in sections of normal human aorta, mammary artery, and saphenous vein.

33 ls cultured from saphenous vein and internal mammary artery, bacterial lipopolysaccharide triggered t

34 d that patients receiving bilateral internal mammary artery (BIMA) conduits during coronary artery by

35 ntial survival benefit of bilateral internal mammary artery (BIMA) grafting in comparison with single

36 shown the superiority of bilateral internal mammary artery (BIMA) grafting over single internal mamm

37 90 interaction was detected in human normal mammary arteries but was absent from human atherosclerot

38 asma and in saphenous vein (but not internal mammary artery) but also increased levels of the oxidati

39 Coronary stenting (STENT) and left internal mammary artery bypass grafting of the LAD (LIMA-LAD) are

40 revascularization ranges from left internal mammary artery bypass grafting via sternotomy and minith

41 demonstrate alpha(1a) and alpha(1b)-mediated mammary artery contraction.

42 The superior long-term patency of internal mammary artery coronary bypass grafts compared with veno

43 In human internal mammary arteries, depressed endothelium-dependent relaxa

44 test the effect of permanent right internal mammary artery device closure on coronary collateral fun

45 Permanent right internal mammary artery device closure seems to augment extracard

46 mination 6 weeks after distal right internal mammary artery device closure.

47 d 86.9% of vein graft, and 91.6% of internal mammary artery distal anastomotic sites had <50% stenosi

48 ase for much wider use of bilateral internal mammary arteries during CABG, and off-pump CABG may be b

49 Finally, in human internal mammary artery, endothelial GR is found to be highly nuc

50 The use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (C

51 rterial conduits, in particular the internal mammary arteries, for coronary bypass surgery whenever p

52 e determined in saphenous veins and internal mammary arteries from 117 patients undergoing CABG.

53 Finally, segments of internal mammary arteries from 26 patients were used in ex vivo e

54 ntified in both saphenous veins and internal mammary arteries from 45 diabetic and 45 matched nondiab

55 idence that patients who receive an internal mammary artery graft (IMA) during coronary artery bypass

56 urgeon effects, and care processes (internal mammary artery graft and perioperative medications use).

57 as better for patients receiving an internal mammary artery graft than those receiving vein grafts on

58 ts associated with the durable left internal mammary artery graft to the left anterior descending art

59 arch of associated CAD, wide use of internal mammary artery graft, and vigorous efforts for secondary

60 Internal mammary artery grafting was adopted slowly and still sho

61 ever, it was similar to that in new internal mammary artery grafts (30.0%).

62 me number of total grafts but fewer internal mammary artery grafts (72% versus 85%, P<0.01), and thos

63 quently, these patients have patent internal mammary artery grafts and require isolated intervention

64 Internal mammary artery grafts were associated with improved outc

65 iabetes, poststernotomy septicemia, internal mammary artery harvest, use of intra-aortic balloon pump

66 anterior thoracotomy using the left internal mammary artery has been performed in some centers with e

67 ibiotic prophylaxis, and use of the internal mammary artery have been advocated as quality indicators

68 It has been established that internal mammary arteries (IMA) are resistant to the development

69 is limited to patients receiving an internal mammary artery (IMA) graft and is apparent earlier in in

70 A single internal mammary artery (IMA) graft has proven survival benefits,

71 The influence of an internal mammary artery (IMA) graft on long-term outcomes after p

72 rcutaneous revascularization of the internal mammary artery (IMA) graft.

73 tive miniCABG cases performed using internal mammary artery (IMA) grafting +/- coronary stenting were

74 sess the pattern of the adoption of internal mammary artery (IMA) grafting in the United States, test

75 dvantages of using routine multiple internal mammary artery (IMA) grafts for coronary artery bypass (

76 of saphenous vein grafts (SVG) and internal mammary artery (IMA) grafts.

77 tery bypass graft surgeries with an internal mammary artery (IMA) have better long-term survival.

78 The internal mammary artery (IMA) is considered the gold-standard con

79 Because the internal mammary artery (IMA) is often visualized during coronary

80 The internal mammary artery (IMA) is the preferred conduit for bypass

81 (DCA) and control samples from the internal mammary artery (IMA) of 7 patients undergoing bypass gra

82 infection in human coronary artery, internal mammary artery (IMA), and saphenous vein (SV).

83 preferable graft, secondary to the internal mammary artery (IMA).

84 Internal mammary arteries (IMAs) and saphenous veins (SVs) were c

85 Segments of internal mammary arteries (IMAs) with their perivascular adipose

86 ethyl ester-inhibitable O(2)(.-) in internal mammary arteries independently of low-density lipoprotei

87 urgical technique by which the left internal mammary artery is anastomosed under direct visualization

88 the combined use of left and right internal mammary arteries (LIMA and RIMA) - collectively known as

89 ry (CABG); all received RA and left internal mammary artery (LIMA) grafts.

90 Use of the left internal mammary artery (LIMA) in multivessel coronary artery dis

91 cy of early occlusion when the left internal mammary artery (LIMA) is anastomosed to the left anterio

92 he LAD was performed using the left internal mammary artery (LIMA).

93 les with age (<55 versus > or = 65 years) in mammary artery (no change in saphenous vein), accompanie

94 e determined in saphenous veins and internal mammary arteries obtained during surgery.

95 n of arginase was determined in the internal mammary artery of patients undergoing bypass surgery.

96 ary artery/SV (n=589) and bilateral internal mammary artery only (n=271) had improved 15-year surviva

97 lly, in tissue segments from either internal mammary artery or saphenous vein, both forskolin and 8-B

98 dial artery is greater than that of internal mammary artery or saphenous vein.

99 II did not contract these arteries, internal mammary arteries, or either type of vein, but it was a p

100 We describe a pedicled internal mammary artery osteomyocutaneous chimeric flap (PIMOC) f

101 33.7%, compared with 4.8% for left internal mammary arteries (P<0.0001), and had a severe stenosis r

102 grafts (P=0.0003) and 4.8% for left internal mammary arteries (P<0.0001).

103 .001]), and patients with bilateral internal mammary artery/radial artery (n=147) and LIMA/radial art

104 t internal mammary artery, 12 right internal mammary artery/radial, and 439 veins), 97 (12%) angiogra

105 ve coronary perfusion plus the left internal mammary artery), reperfusion B (saphenous vein graft per

106 Segments of internal mammary artery responded in a similar manner.

107 , 1.4+/-1.0%, and 3.8+/-0.8% in the internal mammary arteries, saphenous veins, and normal coronary a

108 l subcutaneous resistance arteries, internal mammary arteries, saphenous veins, and small subcutaneou

109 re quantified in saphenous vein and internal mammary artery segments.

110 grafting in comparison with single internal mammary artery (SIMA) grafting has been emphasized by ma

111 artery (BIMA) grafting over single internal mammary artery (SIMA) grafting in select populations.

112 vival than those receiving a single internal mammary artery (SIMA), data on risk of repeat revascular

113 Internal mammary artery specimens were obtained from patients who

114 in perivascular (saphenous vein and internal mammary artery) subcutaneous and mesothoracic adipose ti

115 MultArt subgroups with bilateral internal mammary artery/SV (n=589) and bilateral internal mammary

116 nt survival benefits with bilateral internal mammary arteries, there is no evidence for clinical bene

117 d on experience with using the left internal mammary artery to bypass the left anterior descending co

118 left anterior thoracotomy and left internal mammary artery to LAD grafting without the use of cardio

119 om Phase I in aspirin prescription, internal mammary artery use, and duration of intubation persisted

120 The use of internal mammary artery was marginally lower in blacks than in wh

121 The left internal mammary artery was used in 62 patients, and 61 patients

122 of 2.4 grafts was placed, and a new internal mammary artery was used on 47 occasions.

123 The left internal mammary artery was used to preferentially graft the left

124 Samples of saphenous veins and internal mammary arteries were collected from 219 patients with c

125 s, cultured from saphenous vein and internal mammary artery, were exposed to 20 micrograms/mL of bact